Macrolactam immunomodulators (tacrolimus and pimecrolimus): New horizons in the topical treatment of inflammatory skin diseases

Marcelo H. Grunwald, Dan Ben Amitai, Boaz Amichai

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Abstract

Tacrolimus and pimecrolimus are new macrolactam immunomodulators which were developed for the treatment of inflammatory skin diseases, mainly atopic dermatitis. In this article, we review the pharmacologic properties of the drugs, their side effects, and their clinical uses.

Original languageEnglish
Pages (from-to)592-602
Number of pages11
JournalJournal of Dermatology
Volume31
Issue number8
DOIs
StatePublished - 1 Jan 2004

Keywords

  • Macrolactam immunomodulators
  • Pimecrolimus
  • Tacrolimus

Fingerprint

Dive into the research topics of 'Macrolactam immunomodulators (tacrolimus and pimecrolimus): New horizons in the topical treatment of inflammatory skin diseases'. Together they form a unique fingerprint.

Cite this